Nasus Pharma collaborates with Aptar to support development and commercialization of NS002: Tel Aviv Saturday, October 11, 2025, 12:00 Hrs [IST] Nasus Pharma Ltd, a clinical-stage ...
Chugai Pharma concludes license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist: Tokyo Saturday, October 11, 2025, 11:00 Hrs [IST] Chugai Pharmaceutical ...
The World Health Organization (WHO) is convening a Guideline Development Group (GDG) for the development of evidence-based recommendations on Human T-cell lymphotropic virus-1 (HTLV-1). HTLV-1 – the ...
EY-Parthenon and FICCI releases a report titled 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently’ ...
AstraZeneca announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader ...
AFDLHF survey reveals cough syrups dispensed in Mumbai & Maharashtra without valid prescription: Shardul Nautiyal, Mumbai Saturday, October 11, 2025, 08:00 Hrs [IST] In an indepen ...
Bayer Consumer Health to develop digital to grow in Indian market: Gireesh Babu, New Delhi Saturday, October 11, 2025, 08:00 Hrs [IST] Bayer Consumer Health division, a part of Ge ...
AiMeD welcomes faster GST refunds; requests measures to enhance system: Our Bureau, New Delhi Saturday, October 11, 2025, 08:30 Hrs [IST] The Association of Indian Medical Device ...
CDSCO initiates discussion on creating level playing field in new drug approvals: Our Bureau, New Delhi Saturday, October 11, 2025, 08:00 Hrs [IST] The Central drug regulator has ...
High upfront costs of advanced measurement instruments hinder pharma MSME access: Prashant Sinha: Nandita Vijayasimha, Bengaluru Saturday, October 11, 2025, 08:00 Hrs [IST] Indias ...
TN and MP pharma leaders mandate stricter quality control measures to retain global credibility: Peethaambaran Kunnathoor, Chennai Saturday, October 11, 2025, 08:00 Hrs [IST] In t ...
Emalex Biosciences’ Expanded Access Programme for investigational Tourette syndrome drug, ecopipam receives US FDA authorization: Chicago Friday, October 10, 2025, 18:00 Hrs [IS ...